Código QR (código de barras bidimensional)

NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.

<h4>Purpose</h4>NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to explore the potential for NY-ESO-1 antigen directed immunotherapy in triple negative breast cancer (TNBC) by determining the frequency...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Principais autores: Foluso O Ademuyiwa, Wiam Bshara, Kristopher Attwood, Carl Morrison, Stephen B Edge, Adam R Karpf, Smith A James, Christine B Ambrosone, Tracey L O'Connor, Ellis G Levine, Anthony Miliotto, Erika Ritter, Gerd Ritter, Sacha Gnjatic, Kunle Odunsi
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science (PLoS) 2012-01-01
Serier:PLoS ONE
Online adgang:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0038783&type=printable
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!